Financial Results - Enveric Biosciences, Inc. reported its financial results for Q1 2025, ending March 31, 2025[4] - The report does not include specific financial figures or performance metrics in the provided content[4] - The financial results include key metrics that will be detailed in Exhibit 99.1, which is referenced in the report[4] - The press release is furnished as Exhibit 99.1, which may contain detailed financial data[6] Corporate Update - The company issued a press release on May 14, 2025, providing a corporate update alongside the financial results[4] - The report is filed under Form 8-K, indicating compliance with the Securities Exchange Act of 1934[5] Company Information - The company is registered on The Nasdaq Stock Market under the trading symbol ENVB[2] - Enveric Biosciences is classified as an emerging growth company[3] - The company is headquartered in Naples, FL, with a principal executive office address provided[1] - Joseph Tucker, Ph.D., serves as the Chief Executive Officer of Enveric Biosciences, Inc.[9]
Enveric Biosciences(ENVB) - 2025 Q1 - Quarterly Results